J. Cole fans started their week off with a bang after he announced that he is dropping a new album, KOD, this Friday (April 20). The Fayetteville rapper hosted a secret and exclusive listening session ...

The average one-year price target for Kodiak Sciences (NasdaqGM:KOD) has been revised to $28.05 / share. This is an increase ...

J. Cole only gave fans four days’ notice before dropping his new studio album, KOD, on Friday, but that didn’t stop them from catapulting the project to record-breaking heights in its first day of ...

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is ...

J. Cole needs little introduction. His music and success speaks for itself. A decade of mixtapes, tours and airtight album rollouts have placed the Jay-Z neophyte at the head of the table. From his ...

In keeping with his activist turn on 2016’s 4 Your Eyez Only, J. Cole’s new album, KOD, is an exploration of addiction. The title has three different meanings that all speak to this aim: Kids On Drugs ...

Shares of Kodiak Sciences KOD rallied 29.6% on Monday after an eminent financial services company, Jefferies, upgraded KOD to a “BUY” rating stating that the company has a major “turnaround story” in ...

We all know the ‘Parental Advisory: Explicit Content’ warning that graces the front of certain albums – an especially iconic badge of honour in hip-hop – but J. Cole has a far more precise disclaimer ...

A month has gone by since the last earnings report for Kodiak Sciences Inc. (KOD). Shares have added about 10.5% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...